Media, Video 12 May 2022 Remplirâ„¢ Channel 7 News feature Clinical trial participant Damian Hall was featured in a national news story by Channel 7 News Reporter, Alison Fan, to… Orthocell
Media, Video 22 Mar 2022 VIDEO | Proactive Investors – March 2022 Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in… Orthocell
Media, Video 02 Sep 2021 Video | Proactive Investors – September 2021 Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in… Orthocell
Media, Video 03 Aug 2021 Video | Proactive Investors – Orthocell highlights potential for CelGro in treatment of lymphedema Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGroâ„¢ with… Orthocell
Media, Video 27 Jun 2021 Video | Stockhead Investor Presentation – June 2021 Orthocell CEO and Managing Director Paul Anderson spoke with Oriel Morrison as part of Stockhead V-Con Biotechs. Orthocell
Media, Video 22 Jun 2021 Video | Ticker News Interview – June 2021 Orthocell CEO and Managing Director, Paul Anderson, spoke with Ticker News about the positive findings from our CelGroâ„¢ clinical study. Orthocell
Media, Video 22 Jun 2021 Video | Proactive Investors – June 2021 Orthocell CEO and Managing Director Paul Anderson discusses with Proactive positive nerve regeneration results one year on from a study… Orthocell
Video 21 Jun 2021 Orthocell (ASX:OCC) demonstrates potential to return function to paralysed limbs Orthocell has been featured in The Market Herald, following the announcement of clinical data from the CelGro nerve regeneration trial… Orthocell
Media, Video 27 May 2021 Video | Proactive Investors – May 2021 Orthocell CEO and Managing Director Paul Anderson speaks to Proactive following the announcement newly granted patents for its CelGroâ„¢ collagen… Orthocell
Video 06 Jan 2021 Australia’s TGA approves Orthocell’s Celgroâ„¢ regenerative collagen medical device Orthocell CEO Paul Anderson spoke to BioWorld, following marketing clearance from Australia’s Therapeutic Goods Administration (TGA) for our Celgroâ„¢ collagen… Orthocell
